1 4-Amino-7-hydroxy-2-methyl-5, 6,7,8,-tetrahydrobenzo[b]thieno [2,3-b]pyridine-3-carboxylic acid, but-2-ynyl ester (SB-205384) and other g-aminobutyric acid A (GABA A ) receptor modulators were tested for their eects on GABA-activated chloride currents in rat cerebellar granule cells by use of the whole-cell patch clamp technique. 2 The major eect of SB-205384 on GABA A -activated current was an increase in the half-life of decay of the response once the agonist had been removed. This is in contrast to many GABA A receptor modulators that have previously been shown to potentiate GABA-activated currents. 3 This pro®le could be explained if SB-205384 stabilizes the channel in open and desensitized states so that channel closing is dramatically slowed. Such a modulatory pro®le may produce a novel behavioural pro®le in vivo.
Introduction
Ligands that modulate the function of g-aminobutyric acid A (GABA A ) receptor gated chloride channels have important therapeutic properties. Agents that increase chloride current ow have sedative, anaesthetic, hypnotic, anxiolytic and anticonvulsant actions. These modulatory eects are produced by interactions at a range of distinct allosteric binding sites on the GABA A channel complex. For two of the major classes, the benzodiazepines and barbiturates, the molecular mechanism of action of the modulators has been described at the single channel level (Study & Barker, 1981) . Benzodiazepines, such as diazepam, increase the anity of the receptor for GABA causing a leftward shift in the GABA dose-response curve and increasing the rate of channel opening at any submaximal GABA concentrations. Barbiturates, such as pentobarbitone, act by increasing the mean open time of the channel, resulting in an increase in maximal current evoked by GABA (Twyman et al., 1989) . Steroid modulators exempli®ed by 5a-pregnane3a,21-diol-20-one (THDOC) share some similarities with benzodiazepines. THDOC increases the frequency of channel opening at the single channel level but these compounds to not interact with the benzodiazepine binding site (Puia et al., 1990) . At the macroscopic current level, the main eect of all three classes of modulator is to increase the peak amplitude of GA-BA A channel currents evoked by submaximal doses of GABA.
In the course of work aimed at identifying novel types of GABA channel modulator, we examined the properties of 4-amino-7-hydroxy -2 -methyl -5, 6,7,8 -tetrahydrobenzo[b] thieno [2,3-b] pyridine-3-carboxylic acid, but-2-ynyl ester (SB-205384) (Figure 1 ) (Benham et al., 1994) , one of a group of related benzothiophene compounds which have a non benzodiazepine modulatory site (Benham et al., 1995) . We compared the modulatory actions of this compound with diazepam, pentobarbitone and THDOC representing the classes described above and tracazolate (Goldberg et al., 1983) , a non benzodiazepine modulator whose actions on GABA A currents have not been directly examined. Electrophysiological studies on cultured cerebellar granule cells revealed that SB-205384 had a novel mechanism of action, dramatically prolonging the decay of GABA-activated current on removal of agonist. Eect on peak GABA-activated current was in contrast much less marked. Since an important function of neurones is to integrate a variety of synaptic inputs over time, this temporal modulatory eect on GABA-gated currents may result in a novel behavioural pro®le in vivo.
Methods

Cell culture
Rat cerebellar granule cells were obtained from 8 day old rats as described by Levi et al. (1989) . The cells were plated on poly-ornithine coated coverslips and were maintained in culture 8 ± 10 days before recording.
Electrophysiology
Cells were placed on the stage of an inverted microscope and continuously superfused (4 ± 6 ml min
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) with a solution containing (mM): NaCl 140, KCl 2.5, CaCl 2 1.5, MgCl 2 1.2, HEPES 10 and glucose 10 (pH 7.4 with NaOH). The patch pipette solution contained in mM: CsCl 140, MgCl 2 4, HEPES 10, EGTA 10 and NaATP 2 and was adjusted to pH 7.2 with CsOH. SB-205384 and THDOC were made up as 10 mM stock solutions in dimethyl sulphoxide, pentobarbitone as a 10 mM stock solution in deionized water, and diazepam and tracazolate as 1 mM stock solutions in slightly acidi®ed deionized water (3 drops 5 M HCl in 20 ml H 2 O) before being diluted to their ®nal concentrations in external solution.
All experiments were performed at room temperature (20 ± 258C). Recordings were made by use of the whole-cell patch clamp technique (Hamill et al., 1981) with a List EPC7 patch clamp ampli®er. Cells were held at a membrane potential of 760 mV. Currents were evoked in response to a pulse of GABA or GABA plus the test compound applied through the perfusion system for approximately 4 s. Current responses were evoked at approximately 60 s intervals and were stored on the computer for later analysis by voltage and patch clamp software (Cambridge Electronic Design). The perfusion system operated by gravity and used large bore tubing placed directly in line with the cell. Solutions were separated by an air bubble that was removed just before the solutions reached the cell via a small hole in the top of the tubing. This system allowed rapid solution exchange at the cell surface with exchange possible within approximately 200 ms. This was tested by changing the external solution between distilled water and 2 M KCl and measuring the rate of change of current. Thus, half times for decay of current of less than about 250 ms would not be distinguishable from solution exchange times. From dose-response curves to GABA, a concentration of GABA that gave approximately 20% of the maximum response was chosen for investigating the action of the GABA modulators. Half times for decay of current (t 1/2 ) were measured by calculating the time taken for the plateau current measured before GABA removal to decay to half its amplitude. All values are given as mean+s.e.mean.
Materials
The following compounds were used: g-amino-n-butyric acid (GABA; Sigma), diazepam (Fabbrica Italiano Sintetica S.p.A.), pentobarbitone sodium (Sigma), muscimol (Sigma), 5a-pregnane-3a,21-diol-20-one (THDOC; Sigma), 4-amino-7-hydroxy -2-methyl-5, 6,7,8-tetrahydrobenzo[b] thieno [2,3-b] pyridine-3-carboxylic acid, but-2-ynyl ester (SB-205384; Dept. of Medicinal Chemistry, SB, Harlow), tracazolate (ICI Pharmaceuticals), cis amino crotonic acid (CACA; Tocris Cookson).
Results
GABA application (0.1 to 1000 mM) to cerebellar granule cells after 8 days in culture consistently evoked rapidly rising inward currents at 760 mV holding potential ( Figure 2a ) with EC 50 3.4 mM (Figure 2b ). Maximal currents of 2.4 nA were recorded under these conditions. These responses were consistent with chloride current¯ow through GABA A channels.
Many GABA channel modulators induce current¯ow in the absence of GABA (Cottrell et al., 1987) , so we ®rst applied SB-205384 in the absence of GABA to assess any direct agonist eect and contribution of this mechanism to responses upon coapplication. Application of 10 mM SB-205384 alone gave a current after 4 s of application (i.e. the GABA application time used in the modulator experiments) that was 2.7+0.9% (n=9) of the peak current observed to an application of 100 mM GABA. Application of either 1 mM or 30 mM SB-205384 alone failed to produce any direct current (n=4). Thus maximal contribution of a direct agonist eect of SB-205384 was about 10% of the EC 20 GABA response. This direct eect was too small to account for the slowly deactivating current on washout of coapplied GABA and SB-205384 described subsequently. Simple addition of a GABA-evoked agonist current and an SB-205384-evoked agonist current does not explain the data.
In order to investigate the eects of GABA modulators on GABA-induced chloride currents it was important to ®rst ascertain a concentration of GABA to enable the consistent detection of any change in the response. A concentration of GABA of 1 mM was chosen for use in subsequent experiments. This concentration gave approximately 20% of the maximum response to GABA (EC 20 0.6 mM, Figure 2b ). This allowed a large window for potentiation whilst still having the potential to show up any inhibition. Control responses were obtained to 1 mM GABA which was then reapplied with increasing concentrations of the modulator compounds. Pretreatment with the modulator rather than coapplication had no signi®cant eect on the peak responses measured, or the time course of the decay of current, so we used coapplication for all subsequent experiments.
Examples of original traces showing the eect of coapplying diazepam and then SB-205384 with GABA (1 mM) are shown in Figure 3 . All compounds gave some degree of potentiation of inward current amplitude. However, in addition to this effect, tracazolate and SB-205384 slowed the decay of the inward current on GABA washout, such that the current now took many seconds to relax back to basal levels (Figure 3 lower  trace) . Figure 4a summarizes the eect of the various modulators on the amplitude of the control GABA response. The control GABA response was taken as 100%. All the modulators tested show some degree of potentiation of the control current. SB-205384 was more potent than the barbiturate, pentobarbitone, and was virtually equipotent to tracazolate but less potent than the steroid, THDOC. Diazepam only gave a very small degree of potentiation at all concentrations tested (maximum potentiation only 44% above control).
Decay of GABA-activated currents in granule cells is multiexponential (e.g. Maconochie et al., 1994) . Such detailed analysis was inappropriate in these experiments due to the limitations of our solution exchange confounding the analysis of fast components. Values for t 1/2 were therefore measured to give a robust indication of modulator-induced changes in decay rate. Figure 4b shows the eect of the various modulators on the half-life of decay of the GABA-activated current on removal of agonist from the same experiments analysed in Figure 4a . SB-205384 and tracazolate both dramatically prolonged the half-life for decay of the GABA response in a concentration-dependent manner. At the highest concentration of SB-205384 used, the half-life of decay was increased about 10 fold compared to control responses. THDOC also caused a prolongation of the half-life of decay at 1 mM. This prolongation was of similar magnitude to that observed for SB-205384 at the same concentration. However, at 1 mM, THDOC potentiated GABA-induced currents to a far greater extent than SB-205384. The other standard compounds (diazepam, pentobarbitone) had very little eect on the decay time of the response, whilst still causing potentiation of the response. Thus the major action of SB-205384 and tracazolate was to prolong the duration of GABA-activated current rather than increase the amplitude of the response, as was seen with the other modulator compounds.
In order to investigate further the mechanism of action of SB-205384, the agonist dependence of SB-205384 modulation was examined. This might indicate if SB-205384 was acting by increasing the anity of the receptor site for agonist, as is thought to be the case for diazepam, or acting on a mechanism discrete from agonist binding. The eect of SB-205384 on the half-life of decay for three agonists with dierent anities for the GABA A receptor was investigated. The concentrations of agonists were chosen to give the same absolute responses in order to generate the same proportion of channels in the open state. CACA was approximately 200 fold less potent than GABA or muscimol, producing a similar response at 0.5 mM to that produced by GABA or muscimol at 1 mM. There was little dierence in the half-life of decay that we observed for each agonist alone (CACA 0.23+0.07 s (n=3), GABA 0.18+0.02 s (n=12) and muscimol 0.43+0.12 s (n=3)). This was expected as the resolution of the recording system was insucient to distinguish the faster decay rate predicted for CACA due to its low anity. However, in the presence of 1 mM SB-205384 decay times were dramatically slowed and therefore able to be resolved above the time constant of the solution exchange. Interestingly the half time varied less than 4 fold between the responses to CACA (0.46+0.09 s, n=3), GABA (0.70+0.08 s, n=12) and muscimol (1.78+0.42 s, n=3) in the presence of SB-205384. This is in contrast to the 200 fold range in their potencies. This suggests that the modulation by SB-205384 is relatively independent of the agonist used.
As the slowing of channel closing did not seem to be due to a direct eect on agonist binding, we next examined the eect Figure 1 The structure of SB-205384. The D logP was measured as +3.91 using the procedure de®ned by Young et al. (1988) .
of a desensitizing GABA concentration on the action of SB-205384. We compared the actions of SB-205384 on responses elicited to 1 mM GABA, which showed little desensitization (Figures 2a and 3) and to 100 mM GABA, which showed rapid desensitization decaying to less than 10% of the peak response during 4 s application (Figure 2a) . Amplitudes of peak and plateau current evoked by 1 mM GABA were altered to a similar degree by 10 mM SB-205384. The peak amplitude was increased to 252+48% of the control peak response (n=7), whilst the plateau was increased to 233+49% control plateau response (n=7). In contrast the currents induced by 100 mM GABA were inhibited by 10 mM SB-205384, with the plateau current showing a greater reduction to 67+5% of control plateau current, n=4, than the peak of the response (86+4% of control peak response, n=4). Responses to 100 mM GABA had a greater half-life of decay (0.45+0.05 s (n=4)) than responses to 1 mM GABA (0.15+0.03 s (n=7)). Coapplication of 10 mM SB-205384 still increased the half-life of decay of the response to 100 mM GABA to 3.24+0.41 s (n=4). For comparison the half-life of decay for coapplication with 1 mM GABA was 1.64+0.25 s (n=7). Thus SB-205384 did not increase the maximum current evoked by 100 mM GABA but the half-life decay was dramatically increased, as seen at the lower dose of 1 mM GABA.
Discussion
The present study shows that the main action of SB-205384 on GABA-gated chloride currents in cerebellar granule cells is to slow signi®cantly the decay of current following agonist removal, in contrast to the dominant action of many existing GABA channel modulators of potentiating peak current.
In the absence of modulators GABA-gated currents show complex decay rates. Puia et al. (1994) used outside-out patches from granule cells in cerebellar slices to show two components to GABA currents of 3 and 70 ms (the 70 ms component representing less than 50% of decay). Time constants of 10 and 170 ms have been recorded from granule cells in culture (Maconochie et al., 1994) . In both studies short millisecond applications of 1 mM GABA were used. A study with cultured hippocampal neurones has revealed a similar pattern of behaviour (Jones & Westbrook, 1995) . These results suggest that the slow component of deactivation (time constant, 100 ± 200 ms) is in fact a result of entry of channels into a desensitized state from which the channel can reopen before closing. Our experimental protocol used lower GABA concentrations at longer application times, a protocol that is also likely to produce a signi®cant slow component to deactivation.
Existing GABA modulators, such as diazepam and pentobarbitone that have been studied in detail, either increase GABA anity (diazepam) or stabilize channels in the open state increasing mean open time (pentobarbitone). Neither of these molecular actions results in a dramatic slowing of macroscopic channel closing.
We chose to measure the half-time of decay rather than multiexponential rate constants as we lacked very fast temporal resolution and the microscopic kinetics in a system where several types of GABA channel are expressed is very complex. This has the advantage of clearly representing the dominant time constant in one value, but the half-time of decay does not directly relate to multiple reaction rates in kinetic models. Hence, we have not tried to present a detailed kinetic description of the mode of action. However, the profound slowing of decay rate by SB-205384 suggests that the GABA-gated channels have been stabilized in a set of states oscillating between open and desensitized such that ultimate channel closing was very much slowed. If so, the slow current decay rate re¯ects the slow exit of channels from the drug bound desensitized state to the open state and then their rapid closing. In the presence of GABA the mean P o of the channels was little changed by SB-205384 so that the macroscopic current showed little potentiation. SB-205384 had similar eects on current decay if most of the channels were driven into the desensitized state by application of high concentrations of GABA (100 mM). This suggests that the drug bound state can be entered readily from both open and desensitized states. The dierential eects on peak current at low and high GABA concentrations appear complex but could be explained by a dual eect of small increases in channel mean open time increasing peak current at low GABA concentrations and a shift in the equilibrium to favour desensitization, which will predominate and tend to decrease current at higher GABA concentrations.
The observation that SB-205384 slows decay rates signi®-cantly when CACA was used as agonist supports a lack of eect on agonist anity. The resolution of our recording system was not suciently fast to see the faster unmodulated decay rate that would be expected for CACA, which was 200 fold less potent than GABA and therefore will unbind faster. If SB-205384 was acting at this step it would be expected that the modulatory eect would be agonist-dependent, such that any slowing of CACA current decay would also be fast to detect in our system. The main conclusion from our analysis is that it is possible to increase the duration of a transient GABA response with very little eect on peak amplitude ± this occurred at low and high GABA concentrations. The implications on synaptic function of various modulatory mechanisms of GABA channel gating have been reviewed by Mody et al. (1994) . As GABA channel kinetics rather than the duration of GABA in the synaptic cleft are most important for determining the time course of the synaptic current, direct modulation of GABA channel kinetics to increase the duration of inward current is likely to have a signi®cant eect on GABA-activated inhibitory postsynaptic currents. Some indication of the behavioural eects of this form of modulation may be derived from in vivo studies on the eects of tracazolate which showed similar modulatory properties to SB-205384. Tracazolate has been shown to be anxiolytic and the main dierences in its pro®le of activity as compared to diazepam is a less potent sedative action and weaker interaction with ethanol (Goldberg et al., 1983) .
In addition to their unique kinetic properties, the overall CNS activity of any agent will also be dependent on the subunit speci®city of the compound. GABA A channels exist as pentameric structures composed of a variety of subunit combinations with speci®c CNS localization (reviewed by Wisden & Seeburg, 1992) . Investigating the activity of SB-205384 on GABA A channels in recombinant expression systems will provide data on subunit speci®city.
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